These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28944834)

  • 21. Long noncoding RNA‑p21 modulates cellular senescence via the Wnt/β‑catenin signaling pathway in mesenchymal stem cells.
    Xia W; Zhuang L; Deng X; Hou M
    Mol Med Rep; 2017 Nov; 16(5):7039-7047. PubMed ID: 28901439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bortezomib inhibits the angiogenesis mediated by mesenchymal stem cells.
    Wang X; Zhang Z; Yao C
    Cancer Invest; 2012 Nov; 30(9):657-62. PubMed ID: 23013101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. microRNA-206 is involved in survival of hypoxia preconditioned mesenchymal stem cells through targeting Pim-1 kinase.
    Zhang Y; Lei W; Yan W; Li X; Wang X; Zhao Z; Hui J; Shen Z; Yang J
    Stem Cell Res Ther; 2016 Apr; 7(1):61. PubMed ID: 27103465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction.
    Bakhashab S; Ahmed FW; Schulten HJ; Bashir A; Karim S; Al-Malki AL; Gari MA; Abuzenadah AM; Chaudhary AG; Alqahtani MH; Lary S; Ahmed F; Weaver JU
    Cardiovasc Diabetol; 2016 Feb; 15():27. PubMed ID: 26861446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of preadipocytes derived from mice fed with high fat diet on the angiogenic potential of endothelial cells.
    Castiglione RC; Barbosa CML; Prota LFM; Marques-Neto SR; Perri-Oliveira M; Helal-Neto E; Morandi V; Barja-Fidalgo C; Bouskela E
    Nutr Metab Cardiovasc Dis; 2018 Sep; 28(9):937-943. PubMed ID: 30111496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
    Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced proangiogenic potential of mesenchymal stem cell-derived exosomes stimulated by a nitric oxide releasing polymer.
    Du W; Zhang K; Zhang S; Wang R; Nie Y; Tao H; Han Z; Liang L; Wang D; Liu J; Liu N; Han Z; Kong D; Zhao Q; Li Z
    Biomaterials; 2017 Jul; 133():70-81. PubMed ID: 28433939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Betaine inhibits in vitro and in vivo angiogenesis through suppression of the NF-κB and Akt signaling pathways.
    Yi EY; Kim YJ
    Int J Oncol; 2012 Nov; 41(5):1879-85. PubMed ID: 22940742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 diabetes alters mesenchymal stem cell secretome composition and angiogenic properties.
    Ribot J; Caliaperoumal G; Paquet J; Boisson-Vidal C; Petite H; Anagnostou F
    J Cell Mol Med; 2017 Feb; 21(2):349-363. PubMed ID: 27641937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conditioned medium from umbilical cord mesenchymal stem cells induces migration and angiogenesis.
    Shen C; Lie P; Miao T; Yu M; Lu Q; Feng T; Li J; Zu T; Liu X; Li H
    Mol Med Rep; 2015 Jul; 12(1):20-30. PubMed ID: 25739039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurotrophin-3 accelerates wound healing in diabetic mice by promoting a paracrine response in mesenchymal stem cells.
    Shen L; Zeng W; Wu YX; Hou CL; Chen W; Yang MC; Li L; Zhang YF; Zhu CH
    Cell Transplant; 2013; 22(6):1011-21. PubMed ID: 23043768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases.
    Ledford KJ; Murphy N; Zeigler F; Bartel RL; Tubo R
    Stem Cell Res Ther; 2015 Mar; 6(1):25. PubMed ID: 25889271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histamine synergistically promotes bFGF-induced angiogenesis by enhancing VEGF production via H1 receptor.
    Lu Q; Wang C; Pan R; Gao X; Wei Z; Xia Y; Dai Y
    J Cell Biochem; 2013 May; 114(5):1009-19. PubMed ID: 23225320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production.
    Huang YH; Wu MP; Pan SC; Su WC; Chen YW; Wu LW
    Angiogenesis; 2013 Jan; 16(1):207-22. PubMed ID: 23086340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial juxtaposition of distinct adult stem cells activates angiogenesis signaling molecules in endothelial cells.
    Mohammadi E; Nassiri SM; Rahbarghazi R; Siavashi V; Araghi A
    Cell Tissue Res; 2015 Dec; 362(3):597-609. PubMed ID: 26068799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanical stretch endows mesenchymal stem cells stronger angiogenic and anti-apoptotic capacities via NFκB activation.
    Zhu Z; Gan X; Fan H; Yu H
    Biochem Biophys Res Commun; 2015 Dec; 468(4):601-5. PubMed ID: 26545780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The angiogenic variation of skeletal site-specific human BMSCs from same alveolar cleft patients: a comparative study.
    Du Y; Jiang F; Liang Y; Wang Y; Zhou W; Pan Y; Xue M; Peng Y; Yuan H; Chen N; Jiang H
    J Mol Histol; 2016 Apr; 47(2):153-68. PubMed ID: 26846721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Mir-155 in Controlling HIF-1α Level and Promoting Endothelial Cell Maturation.
    Yang D; Wang J; Xiao M; Zhou T; Shi X
    Sci Rep; 2016 Oct; 6():35316. PubMed ID: 27731397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Jun N-terminal kinase mediated VEGFR2 sustained phosphorylation is critical for VEGFA-induced angiogenesis in vitro and in vivo.
    Shen K; Ji L; Lu B; Wang Z
    Cell Biochem Biophys; 2012 Sep; 64(1):17-27. PubMed ID: 22592917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
    Hartmann D; Fiedler J; Sonnenschein K; Just A; Pfanne A; Zimmer K; Remke J; Foinquinos A; Butzlaff M; Schimmel K; Maegdefessel L; Hilfiker-Kleiner D; Lachmann N; Schober A; Froese N; Heineke J; Bauersachs J; Batkai S; Thum T
    Circulation; 2016 Dec; 134(24):1973-1990. PubMed ID: 27780851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.